Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	136.86	226.05	95.44
Graham Fair Price	-21.72	49.54	63.29
PEG	-53.41	-1.84	3.95
Price/Book	31.58	26.35	20.03
Price/Cash Flow	418.11	-537.93	103.82
Prices/Earnings	125.80	74.25	32.88
Price/Sales	84.58	68.71	37.22
Price/FCF	418.11	-537.93	103.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.76	0.51	0.51
Operating Margin	-20.42	0.26	0.33
ROA	-38.85	0.03	0.05
ROE	0.15	0.09	-41.73
ROIC	0.11	0.06	-42.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.02	-82.49
Dividends QOQ	< 0.005	< 0.005	-50.04
EBIT QOQ	0.10	-0.42	335.74
EPS QOQ	0.08	-0.40	384.69
FCF QOQ	3.14	-1.26	-59.90
Revenue QOQ	0.08	-0.27	218.31
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	226.32	342.33	51.26
Days Sales Outstanding (DSO)	90.25	101.72	12.71
Inventory Turnover	0.40	0.26	-33.89
Debt/Capitalization	0.26	0.25	-2.17
Quick Ratio	0.88	0.76	-13.70
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.20	35.06	2.54
Cash	17.82	13.74	-22.88
Capex	-1.53	-1.08	29.64
Free Cash Flow	6.60	-1.72	-73.96
Revenue	18.40	13.45	-26.90
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.50	1.54	2.59
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.85	-0.30	64.11
Naive Interpretation	Member

06 - Financial Health · Weak

Rating